Jewish Hospital

About: Jewish Hospital is a healthcare organization based out in Cincinnati, Ohio, United States. It is known for research contribution in the topics: Antigen & Population. The organization has 3881 authors who have published 3414 publications receiving 123044 citations.

Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy

Abstract: Objective To examine the risk of venous thromboembolism (VTE) associated with exposure to testosterone therapy in middle-aged and older men. Patients and Methods We conducted a case-control study of 30,572 men 40 years and older who were enrolled in one of the nation's largest commercial insurance programs between January 1, 2007, and December 31, 2012. Cases were defined as men who had a primary diagnosis of VTE and received an anticoagulant drug in the 60 days after their diagnoses. Cases were matched with 3 controls on event/index month, age, geographic region, diagnosis of hypogonadism, and diagnosis of any underlying prothrombotic condition. Conditional logistic regression analysis was used to calculate adjusted odds ratios (aORs) and 95% CIs for the risk of VTE associated with previous exposure to testosterone therapy. Results Exposure to testosterone therapy in the 15 days before the event/index date was not associated with an increased risk of VTE (aOR, 0.90; 95% CI, 0.73-1.12). None of the specific routes of administration examined were associated with an increased risk of VTE (topical [aOR, 0.80; 95% CI, 0.61-10.41], transdermal [aOR, 0.91; 95% CI, 0.38-2.16], and intramuscular [aOR, 1.15; 95% CI, 0.80-1.64]). These findings persisted using exposure windows that extended to 30 and 60 days before the event/index date. Conclusion Having filled a prescription for testosterone therapy was not associated with an increased risk of VTE in commercially insured middle-aged and older men. These findings may provide clinically relevant information about the benefit-risk assessment for men with testosterone deficiency considering treatment.

ACCUMULATION OF INORGANIC POLYPHOSPHATE IN AEROBACTER AEROGENES I. Relationship to Growth and Nucleic Acid Synthesis

Abstract: Harold, F. M. (National Jewish Hospital, Denver, Colo.). Accumulation of inorganic polyphosphate in Aerobacter aerogenes. I. Relationship to growth and nucleic acid synthesis. J. Bacteriol. 86:216–221. 1963.—Growing cells of Aerobacter aerogenes contain traces of inorganic polyphosphate, but large amounts often accumulate when growth ceases as the result of a nutritional deficiency. The reciprocal relationship between growth and polyphosphate accumulation was traced to competition between nucleic acid synthesis and polyphosphate for intracellular phosphorus. Polyphosphate accumulated only after nucleic acid synthesis had ceased. Resumption of nucleic acid synthesis (with or without concurrent cell growth) induced rapid degradation of the polyphosphate with transfer of the phosphorus to ribonucleic acid (RNA). At the same time, incorporation of P32 into polyphosphate was reduced, though not abolished. Competition for adenosine triphosphate may be part of the explanation. In addition, it appears that polyphosphate degradation is accelerated under conditions which permit rapid nucleic acid synthesis, the phosphorus released being trapped in RNA.

Heritable Thrombophilia-Hypofibrinolysis and Osteonecrosis of the Femoral Head

Abstract: We hypothesized that inherited thrombophilia and hypofibrinolysis were risk factors for osteonecrosis of the femoral head. We compared measures of thrombophilia and hypofibrinolysis in referred new adult patients with idiopathic osteonecrosis (n = 71) or secondary osteonecrosis (n = 62) with the same measures in sex- and race-matched healthy control subjects. Heritable thrombophilic Factor VIII and hypofibrinolytic Lp(a) were more frequently high in the 71 patients with idiopathic osteonecrosis than in control subjects. High Factor VIII, Factor V Leiden heterozygosity, and resistance to activated protein C, all heritable thrombophilias, were more frequently present in the 62 patients with secondary osteonecrosis than in control subjects. Our data suggest inherited thrombophilia and hypofibrinolysis are risk factors for both idiopathic and secondary osteonecrosis of the head of the femur.